RF IgM (Rheumatoid Factor)

The Rheumatoid Factor (RF) IgM ELISA test system is intended for the qualitative and semi-quantitative detection of RF IgM-class antibody in human serum. The test system is intended to be used as an aid in the diagnosis of rheumatoid arthritis. This test is for in vitro diagnostic use.


Catalog No Size
Product Catalog No: EIA-2775 Pack Size: 96 Wells

Pack Size:
Pack Size:
Pack Size:
Pack Size:

Category:
Assay Principle

The DRG Rheumatoid Factor ELISA test system is designed to detect IgM class antibodies to RF in human sera. Wells of plastic microwell strips are sensitized by passive absorption with RF antigen. The test procedure involves three incubation steps:

  1. Test sera (properly diluted) are incubated in antigen coated microwells. Any antigen specific antibody in the sample will bind to the immobilized antigen. The plate is washed to remove unbound antibody and other serum components.
  2. Peroxidase Conjugated goat anti-human IgM is added to the wells and the plate is incubated. The Conjugate will react with the antibody immobilized on the solid phase in step 1. The wells are washed to remove unreacted Conjugate.
  3. The microwells containing immobilized peroxidase Conjugate are incubated with peroxidase Substrate Solution. Hydrolysis of the Substrate by peroxidase produces a color change. After a period of time the reaction is stopped and the color intensity of the solution is measured photometrically. The color intensity of the solution depends upon the antibody concentration in the original test sample.
Order Enquiry

    Order Enquiry Form

    References
    • Turgeon, M.l_: Rheumatoid Arthritis. In: Immunology and Serology in Laboratory Medicine, 2nd Ed. Shanahan, J., ed. Mosby Year Book Inc., StLouis, MO, Ch.28, pp:387-398.1996.
    • Wilske, K., Yocum, D.: Rheumatoid Arthritis: The Status and Future of Combination Therapy. J. of Rheumatol. Vol 23 (suppl44): 1.1996.
    • Jackson, G.: Immunodeficiences and Autoimmune Disorders, In: Clinical Laboratory Medicine, Titton, R. et. al. Eds. Mosby Year Book Inc., St. Louis, MO. Ch.36, pp:485-504.1992.
    • Richardson, C., Emery, P. Laboratory Markers of Disease Activity. J. of Rheumatol. Vol 23(suppl44), pp:23-30.1996.
    • Zuraw. B., efcal. Immunoglobulin E-Rheumatoid Factor in the Serum of Patients with RA, Asthma, and Other Diseases, J. Clin. Invest., (68),1610. 1981.
    • Wolfe, F. The Natural History of Rheumatoid Arthritis. J. of Rheumatol. Vol.23 (suppl44): 13-22.1996.
    • Procedures for the collection of diagnostic blood specimens by venipuncture -Second edition: Approved Standard (1984). Published by National Committee for Clinical Laboratory Standards.
    • Procedures for the Handling and Processing of Blood Specimens. NCCLS Document H18-A, Vol. 10, No. 12, Approved Guideline, 1990.
    • U.S. Department of Labor, Occupational Safety and Health Administration: Occupational Exposura4o.8toodbgflie_Pflthogens, Final Rule. Fed. Register 56:64175-64+62; 1991.
    Enquiry